Oscar Health, Inc.
Close on Oct 19, 2026
- Market cap
- $10.85B
- P/E (TTM)
- 23.2
- Dividend yield
- –
Earnings
Next report expected Nov 5, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 6, 2026 | Before market open | $4.90B | $1.10 | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 6, 2026 | Before market open | $4.60B | $2.07 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 10, 2026 | Before market open | $2.81B | $-1.24 | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 6, 2025 | Before market open | $2.99B | $-0.53 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Jul 22, 2025 | Before market open | – | – | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 7, 2025 | Before market open | $3.00B | $0.92 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 4, 2025 | After market close | $2.39B | $-0.62 | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 7, 2024 | Before market open | $2.40B | $-0.22 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 7, 2024 | Before market open | $2.20B | $0.20 | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 7, 2024 | Before market open | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Jan 10, 2024 | Before market open | – | – | – |
Company guidance
Outlook given with results on Aug 6, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Earnings from Operations | Full Year 2026 | $500.00M to $700.00M | Raised |
| Medical Loss Ratio | Full Year 2026 | 81.5% to 82.5% | Raised |
| SG&A Expense Ratio | Full Year 2026 | 15.6% to 16.1% | Lowered |
| Total Revenue | Full Year 2026 | $18.70B to $19.00B | Maintained |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Oscar Health filed with the SEC
Oscar Health Announces Record Financial Results for First Half 2026 and Raises Full Year 2026 Outlook
Results of operations · EX-99.1 to Form 8-K
Oscar Health Announces Strong Financial Results for First Quarter 2026 And Reaffirms 2026 Guidance
Results of operations · EX-99.1 to Form 8-K
Oscar Health, Inc. Appoints Director Siddhartha Sankaran as Independent Chair of the Board
Regulation FD disclosure · EX-99.1 to Form 8-K
Oscar Health Announces Financial Results for Fourth Quarter and Full-Year 2025
Material agreement · Results of operations · New financial obligation · EX-99.1 to Form 8-K
Oscar Health Announces Financial Results for Third Quarter 2025 and Reaffirms 2025 Guidance
Results of operations · Other events · EX-99.1 to Form 8-K
$355,000,000 Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market
Agreement terminated · Other events · EX-99.1 to Form 8-K
Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market
Material agreement · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Oscar Health Announces Financial Results for Second Quarter 2025 and Reaffirms Updated 2025 Guidance
Results of operations · EX-99.1 to Form 8-K
Oscar Health Announces Preliminary Financial Results for Second Quarter 2025 and Revises 2025 Guidance
Results of operations · EX-99.1 to Form 8-K
Oscar Health Announces Strong Financial Results for First Quarter 2025 And Reaffirms 2025 Guidance
Results of operations · EX-99.1 to Form 8-K
Oscar Health Announces Fourth Quarter and Full Year 2024 Results; Introduces Full Year 2025 Outlook
Results of operations · Executive or director change · EX-99.1 to Form 8-K
Oscar Health Announces Results for Third Quarter 2024
Results of operations · EX-99.1 to Form 8-K
Oscar Health Announces Results for Second Quarter 2024 and Raises Full Year Revenue and Adjusted EBITDA Outlook
Results of operations · EX-99.1 to Form 8-K
Oscar Health Announces Results for First Quarter 2024
Results of operations · EX-99.1 to Form 8-K
2023 Quarterly and Annual Results of Operations and Key Metrics
Results of operations · EX-99.2 to Form 8-K
Oscar Health Announces Strong Results for Fourth Quarter and Full Year 2023; Introduces Full Year 2024 Outlook Including Total Company Adjusted EBITDA Profitability
Results of operations · EX-99.1 to Form 8-K
Oscar Health, Inc. Announces that Mark Bertolinis Foundation and Deerfield Management have Entered into an Agreement
Regulation FD disclosure · EX-99.1 to Form 8-K
Oscar Health Announces Results for Third Quarter 2023 and Raises Full Year 2023 Adjusted EBITDA Outlook; New +Oscar Agreement
Results of operations · EX-99.1 to Form 8-K
Oscar Health Announces Strong Financial Results for Second Quarter 2023
Results of operations · Executive or director change · EX-99.1 to Form 8-K
Oscar Health Announces Results for First Quarter 2023 With Meaningful YoY Improvements Across all KPIs
Results of operations · EX-99.1 to Form 8-K
Oscar Health Announces Results for Fourth Quarter and Full Year 2022
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
HIOSCAR.COM Oscar Health, Inc. Fourth Quarter and Full Year 2022 Earnings Presentation February 9, 2023
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Oscar Health Announces Results for Third Quarter 2022
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
HIOSCAR.COM Oscar Health, Inc. Third Quarter 2022 Earnings Presentation November 8, 2022
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.2 to Form 8-K
Oscar Health Announces Results for Second Quarter 2022
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
HIOSCAR.COM Oscar Health, Inc. Second Quarter 2022 Earnings Presentation August 11, 2022
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Oscar Health Announces Results for First Quarter 2022
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
HIOSCAR.COMMay 10, 2022 Oscar Health, Inc. First Quarter 2022 Earnings Presentation
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Oscar Health Announces Results for Fourth Quarter and Full Year 2021
Results of operations · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
HIOSCAR.COM Oscar Health, Inc. Fourth Quarter and Full Year 2021 Earnings Presentation February 10, 2022
Results of operations · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Oscar Health Delivers Historic Growth, Issues Guidance for 2022 of More than $6B in Premiums
Material agreement · Results of operations · New financial obligation · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Oscar Health Announces Results for Third Quarter 2021
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
HIOSCAR.COM Oscar Health, Inc. Third Quarter 2021 Earnings Presentation November 10, 2021
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K